Welcome to our dedicated page for Draegerwerk news (Ticker: DGWPF), a resource for investors and traders seeking the latest updates and insights on Draegerwerk stock.
The news page for DRAEGERWERK AG ORD (DGWPF) aggregates coverage related to Dräger, an international medical and safety technology company whose products are used in hospitals, neonatal units, operating rooms, and safety-critical environments. Company announcements highlight developments across anesthesia, ventilation, neonatal care, surgical lighting, respiratory protection, alcohol detection, and digital health solutions.
Recent news items describe Dräger’s work in medical technology, including the Atlan A350/A350XL anesthesia machines, which received an Innovative Technology Product designation from Vizient, and the Evita V800/V600, Babylog VN800, and Savina 300 ventilators, which obtained Authority to Operate certifications under the U.S. Department of Defense Risk Management Framework. Other articles cover the expansion of Dräger’s neonatal care portfolio through the BiliPredics predictive software solution, jaundice measurement devices, and phototherapy lights, as well as extended reality training tools such as the Virtuo XR Babyleo simulator developed with VirtualiSurg.
On the safety technology side, news updates include the launch of the ProAir closed-circuit breathing apparatus for first responders and federal government operations in high-rise, tunnel, subway, maritime, and HAZMAT environments, and the introduction of the Alcotest 7000 alcohol screening device for law enforcement, DOT compliance, and workplace safety. Additional coverage highlights Dräger’s CMMC Level 2 cybersecurity certification for handling Controlled Unclassified Information in the U.S. Department of Defense supply chain and contracts with the U.S. Veterans Health Administration for surgical lighting and equipment booms.
Investors and professionals can use this news stream to follow product launches, government and hospital contracts, cybersecurity and regulatory milestones, extended reality training initiatives, and recognitions from organizations such as Vizient and the Academy of International Extended Reality. Returning to this page provides an ongoing view of how Dräger’s medical and safety technology activities relate to DGWPF.
Dräger announced that its Evita V800/V600 and Babylog VN800 family of mechanical ventilators received Authority to Operate (ATO) certification under the Department of Defense's Risk Management Framework (RMF) eMASS #3984. Additionally, the Savina 300 series received ATO certification under eMASS #3957. Both certifications are effective from January 23, 2025, and expire on January 21, 2028.
This certification follows Dräger's previous achievement with the V500 series ventilators in 2020. The ATO certification represents the highest level of security for medical devices, offering benefits such as enhanced data protection, compliance assurance, and faster integration with hospital systems. These certifications demonstrate Dräger's commitment to cybersecurity and patient data protection.
Dräger has received an Innovative Technology Product designation from Vizient for its Atlan® A350/A350XL Anesthesia Machines. The designation, awarded by Vizient (the largest healthcare performance improvement company in the US), recognizes products that enhance clinical care, patient safety, and healthcare operations.
The Atlan family of anesthesia workstations features an electronic piston ventilator for precise ventilation across all patient ages, extensive safety features, and optimization for low-flow anesthesia. The system includes a Low Flow Wizard tool and recycling of sampled breathing gas, reducing anesthetic agent consumption and environmental impact.
Dräger, which generated revenues of €3.4 billion in 2023 and operates in over 190 countries, is a Vizient Pediatric Program supplier in four categories: Anesthesia Machines, Infant Care and Phototherapy, Ventilators, and OR Lights, Columns, and Booms.
Dräger, a global safety technology leader, has introduced the OXY SR Cap III, an innovative respiratory protective device for emergency escape in extreme underground and confined space environments. This NIOSH-certified device provides 90 liters of oxygen for safe evacuation from life-threatening situations.
Key features include:
- Fast activation and oxygen delivery
- Up to 10 years of maintenance-free service life
- Designed for universal usability with a simple 5-step deployment process
- Automatic activation when the mouthpiece is pulled
- Safety Eye indicator for quick damage assessment
- Cost-effective solution with reduced lifetime costs
The OXY SR Cap III is suitable for mining, tunneling, industrial facilities, railways, and subways, offering critical protection against fire, toxic chemical exposure, and oxygen deficiency.
Dräger has been awarded the 2024 Zenith Award by the American Association for Respiratory Care (AARC), marking the 13th time the company has received this recognition. The award, given to only eight out of over 300 companies, is based on criteria including equipment quality, service, and customer support. Dräger's commitment to the respiratory care profession is highlighted by its continuous investment in new technologies, such as the Evita V600, V800, and Babylog VN800 ventilators.
The company's services include a network of over 3000 technicians, remote service, and 24/7 hotline support. Dräger has also donated more than 320 ventilators to respiratory schools in the United States for training purposes. With revenues of around €3.4 billion in 2023, Dräger operates in over 190 countries with more than 16,000 employees worldwide.
Summary not available.
Summary not available.